EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Gender and COVID-19 Vaccine Disparities in Cameroon

Adidja Amani, Tatiana Mossus, Fabrice Zobel Lekeumo Cheuyem, Chanceline Bilounga, Pamela Mikamb, Jonas Basseguin Atchou, Aude Perine Minyem Ngombi, Armanda Nangmo, Yannick Kamga, Georges Bediang, Joseph Kamgno, Anne-Cécile Zoung-Kanyi Bissek

COVID · 2022-11-30 · 2 (12) · 1715-1730

DOI: 10.3390/covid2120123 ↗
AbstractBibliografische Angaben

Abstract

Six months following the national launch of COVID-19 vaccinations in Cameroon, only 1.1% of the target population was fully vaccinated, with women representing less than one-third of the vaccinated population regardless of age, profession, or comorbidities. Hence, the aim of this study was to understand the low COVID-19 vaccination rate of women in order to enhance vaccine uptake. A cross-sectional study was conducted between July and October 2021 through an online survey. Additionally, a retrospective analysis of the Cameroon Ministry of Public Health (MINSANTE) database of the pandemic (COVID-19) for the period of March 2020 to October 2021 was simultaneously carried out. Our sample consisted of 249 responders aged between 18 and 50 years enrolled in the 10 regions of Cameroon, with 142 (57%) who were female. We assessed factors related to having been vaccinated against COVID-19 and predictors of COVID-19 vaccination among non-vaccinated people. Concerning COVID-19 vaccination, 39.2% were not vaccinated. Non-vaccination was statistically associated with being female, being a healthcare worker, fear of adverse effects, and not believing in the vaccine. In the qualitative analysis, women identified themselves as being anti-COVID-19-vaccine for several reasons, including doubts about the quality or safety of the vaccine; the perception that COVID-19 vaccines are presented as being an obligation; and regarding the multitude of vaccines on the market, the belief that there are “more local” effective alternatives to the vaccine. The implementation of the gender approach to COVID-19 vaccination is one factor influencing its effectiveness and sustainability.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →